The area of Dry Eye Syndrome is an illustrative example, with more than 340 million people affected globally, including about 40 million in the US – suffering from inflammation, nerve pain, light ...
QuidelOrtho has launched the QuickVue Influenza + SARS Test for professional use. The test simultaneously detects and differentiates influenza A, influenza B, and SARS-CoV-2 antigens from a single ...
SAN DIEGO, Sept. 22, 2025 /PRNewswire/ -- Building on its leadership in point-of-care diagnostic testing, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho"), a leading global provider of ...
SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho" or the “Company”) has received U.S. Food and Drug Administration (“FDA”) 510(k) clearance for its QuickVue COVID-19 ...
The free at-home COVID-19 test delivery program is back this fall to prepare for expected case increases. Daniella Segura McClatchy News Fall is in full swing, school is in session and the holidays ...
QuidelOrtho Corporation QDEL recently announced the FDA 510(k) clearance for its QuickVue COVID-19 test.With CLIA certificates of waiver, this approval permits the test to be used accurately and ...
(RTTNews) - QuidelOrtho (QDEL) said it has received FDA 510(k) clearance for QuickVue COVID-19 test. The clearance allows the test to be used in home and medical facility settings with CLIA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback